Botulinum toxin therapy for neurogenic detrusor hyperactivity versus augmentation enterocystoplasty: impact on the quality of life of patients with SCI

Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity

(2012) David Sussman et al.   NEUROUROLOGY AND URODYNAMICS

The past, present and future of augmentation cystoplasty

(2011) Suzanne M. Biers et al.   BJU INTERNATIONAL

Effect of repeated detrusor onabotulinumtoxina injections on bladder and renal function in patients with chronic spinal cord injuries

(2011) Hann-Chorng Kuo et al.   NEUROUROLOGY AND URODYNAMICS

Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity

(2010) Priya Padmanabhan et al.   WORLD JOURNAL OF UROLOGY

Recommandations de bonne pratique clinique pour le suivi des patients neurologiques après injection de toxine botulique intradétrusorienne

(2009) M. Sèze et al.   Pelvi-Perineologie

Critères de décision et recommandations de bonne pratique clinique pour la première injection intradétrusorienne de toxine botulique A dans le traitement de l’hyperactivité neurogène du détrusor

(2009) B. Perrouin-Verbe et al.   PROGRES EN UROLOGIE

The relationship between bladder management and health-related quality of life in patients with spinal cord injury in the UK

(2009) C-W Liu et al.   SPINAL CORD

Does Optimizing Bladder Management Equal Optimizing Quality of Life? Correlation Between Health-related Quality of Life and Urodynamic Parameters in Patients With Spinal Cord Lesions

(2009) Jürgen Pannek et al.   UROLOGY

Botulinum Toxin A (Botox®) Intradetrusor Injections in Adults with Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Literature Review

(2007) Gilles Karsenty et al.   EUROPEAN UROLOGY